Ticker: CO, Company: China Cord Blood Corp, Type: SC TO-I/A, Date: 2010-12-13
Original SEC Filing: Click here

---

Webplus: CO/20101213/SC_TO-I.A_1/1/000.htm SEC Original: v205334_sctoia.htm
_____________ SCHEDULE TO (Amendment No. 2) _____________ (Rule 14d-100) Tender Offer Statement under Section 14(d)(1) or 13(e)(1) _____________ CHINA CORD BLOOD CORPORATION (Name of Subject Company (Issuer) and Name of Filing Person (Issuer)) (Title of Class of Securities) KYG211071181 _____________________ ) _____________ Albert Chen +852 3605 8180 albert.chen@chinacordbloodcorp.com 48th Floor, Bank of China Tower 1 Garden Road Central, Hong Kong

---

---

Webplus: CO/20101213/SC_TO-I.A_1/2_EX-99.A.5.F/000.htm SEC Original: v205334_ex99a5f.htm
HONG KONG, China, December 13, – China Cord Blood Corporation Ms. Ting Zheng, Chairperson and CEO of China Cord Blood Corporation commented, “We believe shareholders will appreciate our simplified capital structure. With no further dilution, shareholders will fully enjoy the benefits of our operational accomplishments and robust growth, even on a per share basis. With all the stakeholders’ interests now

---

Company Information:

Ticker: CO, Company: China Cord Blood Corp, Type: SC TO-I/A, Date: 2010-12-13CIK: 0001467808, Location: K3, SIC: 6770, SIC Desc: BLANK CHECKS
Business Phone & Address:
48 FL., BANK OF CHINA TOWER, 1 GARDEN ROAD
CENTRAL HONG KONG, K3 000000